We synthesized a series of bortezomib derivatives that showed CIP2A inhibition activity, and the inhibition of CIP2A-Akt signaling pathway correlated with the cytotoxicity of these derivatives in HCC cells. Here, CIP2A is linked to hepatocellular carcinoma.